Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer. [electronic resource]
Producer: 20200407Description: 320 p. digitalISSN:- 2041-1723
- Antineoplastic Agents, Hormonal -- pharmacology
- Binding Sites
- Breast Neoplasms -- genetics
- CCCTC-Binding Factor -- chemistry
- Chromatin -- chemistry
- DNA Methylation
- Epigenesis, Genetic -- drug effects
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- MCF-7 Cells
- Neoplasm Proteins -- genetics
- Promoter Regions, Genetic -- drug effects
- Protein Interaction Domains and Motifs
- Receptors, Estrogen -- chemistry
- Whole Genome Sequencing
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.